CPN cat Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Guanidinoethylmercaptosuccinic Acid | 77482-44-1 | sc-203769 | 5 mg | $306.00 | 3 | |
2-Guanidinoethylmercaptosuccinic Acid demonstrates intriguing behavior as a CPN cat, particularly through its ability to form stable complexes with metal ions, enhancing its reactivity. The presence of guanidine groups facilitates strong hydrogen bonding and electrostatic interactions, promoting unique pathways in biochemical processes. Its distinct thiol functionality contributes to redox reactions, influencing cellular signaling and metabolic pathways. Additionally, its solubility characteristics allow for effective diffusion in various environments, impacting its kinetic interactions. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
By inhibiting bacterial DNA gyrase, Ciprofloxacin can prevent the necessary supercoiling of the DNA, which may be essential for CPN cat to recognize and bind its recombination sites. | ||||||
Enoxacin | 74011-58-8 | sc-205670 sc-205670A | 500 mg 1 g | $40.00 $49.00 | 2 | |
Similar to Ciprofloxacin, Enoxacin's inhibition of DNA gyrase and topoisomerase IV can impact the DNA's supercoiling and structure, affecting CPN cat's activity. | ||||||
ICRF-193 | 21416-68-2 | sc-200889 sc-200889A | 1 mg 5 mg | $341.00 $927.00 | 7 | |
By inhibiting DNA topoisomerase II, ICRF-193 affects DNA's structure and replication, possibly hindering the DNA regions where CPN cat would act. | ||||||
Aclacinomycin A | 57576-44-0 | sc-200160 | 5 mg | $132.00 | 10 | |
By intercalating into DNA and inhibiting topoisomerase II, Aclacinomycin A could alter the DNA structure, preventing CPN cat from accessing or recognizing its target sites. | ||||||
Lomefloxacin, Hydrochloride | 98079-52-8 | sc-218660 | 1 g | $55.00 | ||
Like other quinolones, by inhibiting DNA gyrase, Lomefloxacin can change DNA topology, which might affect CPN cat's ability to locate and recombine its target sequences. | ||||||
Pefloxacin mesylate dihydrate | 149676-40-4 | sc-204838 | 5 g | $62.00 | ||
Its mechanism is similar to other quinolones, potentially affecting DNA supercoiling and, consequently, CPN cat′s activity. | ||||||
Simocyclinone D8 | 301845-97-6 | sc-364138 | 1 mg | $174.00 | ||
By binding to DNA gyrase, Simocyclinone D8 might prevent the proper supercoiling needed for CPN cat to execute its function effectively. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
By interfering with topoisomerase II, Mitoxantrone can introduce DNA breaks that may compete with or obstruct CPN cat's specific recombination sites. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin's intercalation can affect the DNA structure, and its inhibition of topoisomerase II can introduce competing breaks, potentially limiting CPN cat's access or function. | ||||||